Data / Form D filings / Averna Therapeutics Inc.
Averna Therapeutics Inc.: Form D filings
Averna Therapeutics Inc., a health care company in Watertown, MA, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on March 20, 2026, reports $85 million sold of a $85 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 134 COOLIDGE AVENUE, Watertown, MA, 10022
- Phone
- 972 73 2822600
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2020048
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Amendment | $85,000,000 | $84,999,995 | $5 | 13 | Apr 8, 2024 | sec.gov |
| Apr 21, 2025 | Amendment | $85,000,000 | $43,769,227 | $41,230,773 | 13 | Apr 8, 2024 | sec.gov |
| Apr 17, 2024 | New notice | $85,000,000 | $38,769,227 | $46,230,773 | 13 | Apr 8, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas Barnes | Director, Executive Officer | Chief Executive Officer/President |
| Richard Morris | Executive Officer | Chief Financial Officer |
| Tal Zaks | Director, Executive Officer | |
| Roy Amariglio | Director | |
| Stephen Squinto | Director | |
| Raju Prasad | Director | |
| Michal Silverberg | Director | |
| Nick Olsen | Director | |
| Henry Chen | Director | |
| Dylan Morris | Director |
Other health care companies in Massachusetts that filed recently
- XRHealth, Inc. $3.9 million · Oct 23, 2026
- Fresenius Medical Care Fulshear, LLC $4.4 million · Oct 21, 2026
- Nocturnal Inc. $1.9 million · Oct 20, 2026
- Mikri Inc. $1.4 million · Oct 19, 2026
- Soterya, Inc. $850,000 · Oct 13, 2026
- ArthroMeda, Inc. $8.7 million · Oct 13, 2026
Every Form D from the week of Mar 16, 2026 · All recent filings in Massachusetts · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Averna Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.